Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAL+ATV/r vs TDF/FTC+ATV/r in HIV patients failing NNRTI regimen
NCT01829802Phase 4Unknown
- Start
- May 2014
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV). Status: unknown.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01829802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01829802.